Difference between revisions of "BRCA1 interacting protein C-terminal helicase 1"
Jump to navigation
Jump to search
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''BRCA1 interacting protein C-terminal helicase 1''', abbreviated ''' | [[Image: Serous carcinoma - fallopian tube -- intermed mag.jpg | thumb | right | Micrograph showing [[serous carcinoma of the fallopian tube]], a tumour that may be associated with a BRIP1 mutation. [[H&E stain]].]] | ||
'''BRCA1 interacting protein C-terminal helicase 1''', abbreviated '''BRIP1''', is a tumour suppressor gene that interacts with [[BRCA1]] to help repair double-strand DNA breaks.<ref>URL: [https://www.ncbi.nlm.nih.gov/gene/83990 https://www.ncbi.nlm.nih.gov/gene/83990]. Accessed on: 05 March 2020.</ref> <ref name=NBK1401>URL: [https://www.ncbi.nlm.nih.gov/books/NBK1401/ https://www.ncbi.nlm.nih.gov/books/NBK1401/]. Accessed on: 05 March 2020.</ref> It is a good example of a gene whose mutations cause clinical manifestations that can be dominant or recessive. | |||
It is also known as ''BACH1'' and ''FANCJ''. | It is also known as ''BACH1'' and ''FANCJ''. | ||
Latest revision as of 16:11, 4 November 2024
Micrograph showing serous carcinoma of the fallopian tube, a tumour that may be associated with a BRIP1 mutation. H&E stain.
BRCA1 interacting protein C-terminal helicase 1, abbreviated BRIP1, is a tumour suppressor gene that interacts with BRCA1 to help repair double-strand DNA breaks.[1] [2] It is a good example of a gene whose mutations cause clinical manifestations that can be dominant or recessive.
It is also known as BACH1 and FANCJ.
Disease associations
- Fanconi anemia with biallelic mutations (autosomal recessive manifestation).[2]
- Breast and ovarian cancer with monoallelic mutation (autosomal dominant manifestation).[2]
See also
References
- ↑ URL: https://www.ncbi.nlm.nih.gov/gene/83990. Accessed on: 05 March 2020.
- ↑ 2.0 2.1 2.2 URL: https://www.ncbi.nlm.nih.gov/books/NBK1401/. Accessed on: 05 March 2020.